Biopharmaceutical companies developing cancer treatments need to restart the clinical trials shut down or delayed during the early stages of the coronavirus pandemic. Some are holding back, however, due to a lack of confidence that sufficient eligible patients can be recruited and enrolled in the trials. Recruiting patients into a clinical trial was challenging before COVID-19 hit, and it has only become exponentially more difficult. Sponsors also know many patients have been putting off
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
DoD, Duke, John Hopkins, HJF, physIQ Launch 18-Month COVID-19 Clinical Trial Study
What You Should Know:
- Today, PhysIQ Inc. announced its partnership with Johns Hopkins University, Duke University and The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF), to support a clinical trial to evaluate products for early treatment and post-exposure treatment of COVID-19. The 18-month study will assess disease progression and provide early indication of infection. This DOD-funded initiative will assess the role of continuous biosensor
Read More
Health2047 Spins Out SiteBridge Research Launches to Improve Clinical Trial Access for Small and Community Physician Practices
What You Should Know:
- Health2047, the innovation arm of the American Medical Association, today announced the spinout of a new company, SiteBridge Research, that offers a more accessible way for a broader set of physicians and their patients to participate in clinical research.
- SiteBridge Research creates a network of independent, small practice physicians to gather data from a broader, more inclusive patient population and, ultimately, create more widely applicable clinical
Read More
Syneos, Medable Team Up to Bring Decentralized Clinical Trials to Patients
What You Should Know:
- Syneos Health, a fully integrated biopharmaceutical solutions organization, and Medable, a cloud platform for patient-centered drug development, announced a strategic partnership to bring clinical trials closer to the patient.
- The partnership will deliver new decentralized capabilities to Syneos Health with the aim of increasing clinical trial diversity, while improving patient access and experiences to transform biopharmaceutical product development.
- As part
Read More
Medable Raises $78M to Expand Decentralized Clinical Trials Platform for Patient-Centered Drug Development
What You Should Know:
- Medable, Inc., a Palo Alto, CA-based global platform for decentralized clinical trials today announced $78M in new funding to fuel advances in the delivery of digital and decentralized clinical trials, accelerating the industry’s shift to patient-centered drug development. The funding was led by Sapphire Ventures, along with new investor Obvious Ventures and follow-on investment from existing investors GSR Ventures, PPD, Inc., and Streamlined Ventures.
- This is
Read More
Decentralized Clinical Trials: Surviving & Thriving in the Clinical Research World of COVID-19
As with so many aspects of our daily lives, the impact of the COVID-19 pandemic on clinical trials was both widespread and monumental. Thousands of trials—an estimated 80% of non-COVID-19 trials—came to a halt or were interrupted by the pandemic, which challenged the ability to conduct trials safely and effectively and was complicated by the reality that trials often deal with the populations most at risk from COVID-19 exposure1.
In response, clinical researchers turned to a range of
Read More
Cardinal Health and Deep Lens Collaborate for AI-based Oncology Clinical Trial Matching
What You Should Know:
- Today, Deep Lens and Cardinal Health announced a strategic collaboration that will integrate Deep Lens’ AI-based clinical trial matching solution, VIPER, into community-based oncology practices throughout the Cardinal network. VIPER will be a part of Cardinal Health’s new Navista advanced suite of technology solutions designed to help oncologists improve outcomes, provide high quality care at the best possible cost and select the right care plan at the onset of
Read More
Janssen Taps Komodo Health to Optimize Site Selection and Patient Recruitment for Clinical Trials
What You Should Know:
- Komodo Health today announced a new client engagement with Janssen solidifying its role as the leading life sciences patient data analytics platform. Janssen Research & Development, LLC (Janssen) will be using Komodo's real-world data and AI software to accelerate clinical development. Janssen plans to use Komodo's services to optimize feasibility, site selection and patient recruitment for clinical trials, ultimately driving higher throughput for
Read More
To Advance Health Equity, Put Real-World Cancer Data to Work
Despite decades of scientific progress against cancer, access to treatment remains highly unequal. Some of the reasons — like institutional racism and poverty — are a reflection of our broader society. Other inequities may go unrecognized but are no less damaging. People with underlying health conditions, for example, may be excluded from clinical trials, preventing them from accessing leading-edge treatments and limiting the evidence available to guide their care.
With multiple drivers of
Read More
NeoGenomics Acquires Precision Oncology Platform Trapelo Health for $65M
What You Should Know:
- NeoGenomics, Inc., a provider of cancer-focused genetic testing services and global oncology contract research services announced it has reached an agreement to acquire precision oncology platform Trapelo Health for $65M. The agreement purchase price of $65 million, consists of $35 million in cash on hand and $30 million in NeoGenomics common stock and is expected to close in April 2021.
- Trapelo Health offers a first-of-its-kind, interoperable, decision-support
Read More
